Related references
Note: Only part of the references are listed.The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells
Yinxing Liu et al.
ACTA NEUROPATHOLOGICA (2014)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells
Zonglei Mao et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer
Lei Yang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Expression and Regulation of Prostate Apoptosis Response-4 (Par-4) in Human Glioma Stem Cells in Drug-Induced Apoptosis
Jayashree C. Jagtap et al.
PLOS ONE (2014)
Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT
Jiaxin Tan et al.
TOXICOLOGY LETTERS (2014)
HKH40A downregulates GRP78/BiP expression in cancer cells
T. Kosakowska-Cholody et al.
CELL DEATH & DISEASE (2014)
Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
Sameer Agnihotri et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4
Ravshan Burikhanov et al.
CANCER RESEARCH (2013)
Three-dimensional cell culture: the missing link in drug discovery
Susan Breslin et al.
DRUG DISCOVERY TODAY (2013)
Role of Prostate Apoptosis Response 4 in Translocation of GRP78 from the Endoplasmic Reticulum to the Cell Surface of Trophoblastic Cells
Marie Cohen et al.
PLOS ONE (2013)
Cancer Cells Resistant to Therapy Promote Cell Surface Relocalization of GRP78 Which Complexes with PI3K and Enhances PI(3,4,5)P3 Production
Yi Zhang et al.
PLOS ONE (2013)
Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells
Martin Block et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Geeta Mehta et al.
JOURNAL OF CONTROLLED RELEASE (2012)
A Novel MMP-2 Inhibitor 3-azidowithaferin A (3-azidoWA) Abrogates Cancer Cell Invasion and Angiogenesis by Modulating Extracellular Par-4
Bilal Rah et al.
PLOS ONE (2012)
Overexpression of GRP78 Is Associated With Malignant Transformation in Epithelial Ovarian Tumors
Lee-Wen Huang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3β/β-Catenin Signaling Pathway
Cuixian Li et al.
PLOS ONE (2011)
Glutathione transferases and development of new principles to overcome drug resistance
Andrea Sau et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Tamoxifen-Induced Adduct Formation and Cell Stress in Human Endometrial Glands
Helen Andersson et al.
DRUG METABOLISM AND DISPOSITION (2010)
Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer
Maria Aparecida Nagai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network
Bi-Dar Wang et al.
MOLECULAR CANCER (2010)
Cancer-selective apoptotic effects of extracellular and intracellular Par-4
T. Shrestha-Bhattarai et al.
ONCOGENE (2010)
Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
Ansgar Bruning et al.
BREAST CANCER RESEARCH (2010)
Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU
Christina L. Kline et al.
CANCER BIOLOGY & THERAPY (2009)
The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis
Ravshan Burikhanov et al.
CELL (2009)
Mechanisms of Drug Sensitivity and Resistance in Cancer
Lorraine O'Driscoll
CURRENT CANCER DRUG TARGETS (2009)
Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways
Hiroshi Matsuoka et al.
EXPERIMENTAL CELL RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Recent advances in three-dimensional multicellular spheroid culture for biomedical research
Ruei-Zhen Lin et al.
Biotechnology Journal (2008)
Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis
Jayashree Joshi et al.
EMBO JOURNAL (2008)
Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation
Mansoor M. Ahmed et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
EGFR associated expression profiles vary with breast tumor subtype
Katherine A. Hoadley et al.
BMC GENOMICS (2007)
Inactivation of the candidate tumor suppressor Par-4 in endometrial cancer
Gema Moreno-Bueno et al.
CANCER RESEARCH (2007)
Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells
Sowmyalakshmi Srinivasan et al.
CANCER RESEARCH (2007)
Glucose regulated proteins in cancer progression, drug resistance and immunotherapy
Yong Fu et al.
CANCER BIOLOGY & THERAPY (2006)
Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis
S Boehrer et al.
LEUKEMIA RESEARCH (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Stress induction of GRP78/BiP and its role in cancer
JZ Li et al.
CURRENT MOLECULAR MEDICINE (2006)
Microscale tissue engineering using gravity-enforced cell assembly
JM Kelm et al.
TRENDS IN BIOTECHNOLOGY (2004)
Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells
AM Hui et al.
CANCER RESEARCH (2004)
The use of 3-D cultures for high-throughput screening: The multicellular spheroid model
LA Kunz-Schughart et al.
JOURNAL OF BIOMOLECULAR SCREENING (2004)
Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas
AM Spence et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis
M Bergmann et al.
ANNALS OF HEMATOLOGY (2004)
Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3
D Chendil et al.
CANCER BIOLOGY & THERAPY (2002)
Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies
LA Hazlehurst et al.
CANCER AND METASTASIS REVIEWS (2001)
Multicellular resistance: a paradigm for clinical resistance?
B Desoize et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Share Paper
